Due to the COVID-19 epidemic, the consumption of pharmaceuticals, especially paracetamol, has sharply increased on a global scale. The increasing concentration of analgesic and anti-inflammatory drugs (AAIDs) in the aquatic medium is a global problem for human and aquatic life. Therefore, simple and effective treatment options for removing AAIDs from wastewater after the COVID-19 pandemic are needed. The removal of AAIDs (acetaminophen, acetylsalicylic acid, codeine, diclofenac, ibuprofen, indomethacin, ketoprofen, mefenamic acid, naproxen, and phenylbutazone) from sewage treatment plant (STP) effluents by the prepared magnetite nanoparticles synthesized from red mud (mNPs-RM) is presented for the first time in this study. The removal efficiencies of AAIDs onto mNPs-RM were determined to be between 90% (diclofenac) and 100% (naproxen, codeine, and indomethacin). Acetaminophen (paracetamol) was used as a model compound in kinetic and isotherm model studies. The adsorption of acetaminophen was matched well with the pseudo second order kinetic model. Film diffusion governed its rate mechanism. The Freundlich isotherm model preferably fitted the adsorption data with an adsorption capacity of 370 mg/g at 120 min contact time at pH 7.0 at 25 °C. Furthermore, the regenerated mNPs-RM were used four times without affecting the adsorption capacity and the magnetic separability. mNPs-RM can be used as a simple, inexpensive and effective adsorbent for removing AAIDs from STP effluents. Also, low cost adsorbent obtained from industrial waste could be employed to replace the high cost activated carbons for the adsorption of other micro pollutants in STP effluents.
Supplementary information: The online version contains supplementary material available at 10.1007/s11270-023-06404-7.
Keywords: Anti-inflammatory/analgesic pharmaceuticals; Effluent, magnetic nanoparticles; Red mud; Sewage treatment plant.
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.